[HTML][HTML] The incidence of prostate cancer in Iran: a systematic review and meta-analysis

S Hassanipour, M Fathalipour, H Salehiniya - Prostate international, 2018 - Elsevier
Background Prostate cancer is one of the most common cancers among men. There are
various estimates of prostate cancer incidence from different geographical areas in Iran. In …

Prostate cancer in Iran: trends in incidence and morphological and epidemiological characteristics

R Pakzad, H Rafiemanesh, M Ghoncheh… - Asian Pacific Journal …, 2016 - koreascience.kr
Background: Prostate cancer is second most common cancer in men overall in the world,
whereas it is the third most common cancer in men and the sixth most common cancer in …

Bladder cancer in Iran: an epidemiological review

K Kalan Farmanfarma, N Mahdavifar… - Research and Reports …, 2020 - Taylor & Francis
Purpose Bladder cancer is the sixth most common cancer in Iran. Information about the
epidemiological situation of the disease and its risk factors is necessary for conducting a …

Histopathologic characterization of prostate diseases in Madinah, Saudi Arabia

A Albasri, A El-Siddig, A Hussainy… - Asian Pacific Journal …, 2014 - koreascience.kr
Aims: To delineate the histopathological pattern of prostate diseases and to highlight age
variations in prostate specific antigen (PSA) values and histopathological features. Materials …

Incidence, Gleason score and ethnicity pattern of prostate cancer in the multi-ethnicity country of Iran during 2008-2010

A Basiri, B Eshrati, A Zarehoroki, S Golshan… - Urology …, 2020 - ojs3.sbmu.ac.ir
Purpose: To investigate the geographical incidence, and grade of prostate cancer in Iran
during 2008-2010 and evaluate its relationship with ethnicity. Materials and Methods: Data …

[HTML][HTML] Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer

Y Yang, LJ Zhang, XG Bai, HJ Xu, ZL Jin… - Biomedicine & …, 2018 - Elsevier
Background and objective Gemcitabine (GEM) effectively inhibits bladder cancer
progression in the clinic, but novel combination treatments using multiple drugs are needed …

[HTML][HTML] A systematic review and meta-analysis on incidence of prostate cancer in Iran

A Moradi, M Zamani, E Moudi - Health promotion perspectives, 2019 - ncbi.nlm.nih.gov
Background: Prostate cancer is a global health concern. In Iran, its epidemiology is not
precisely recognized. We aimed to evaluate incidence of prostate cancer among Iranian …

The incidence of hepatocellular carcinoma in Iran from 1996 to 2016: a systematic review and meta-analysis

S Hassanipour, M Mohammadzadeh… - Journal of …, 2019 - Springer
Purpose Hepatocellular carcinoma or liver cancer (LC) is one of most important cancer
around the world. There are several reports about LC incidence from various Iranian …

Results of intravesical chemo-hyperthermia in high-risk non-muscle invasive bladder cancer

RG Ekin, I Akarken, O Cakmak, H Tarhan… - Asian Pacific Journal …, 2015 - koreascience.kr
Purpose: To examine the effectiveness of mitomycin-C and chemo-hyperthermia in
combination for patients with high-risk non-muscle-invasive bladder cancer. Materials and …

[HTML][HTML] The incidence of kidney cancer in Iran: a systematic review and meta-analysis

S Hassanipour, G Namvar, M Fathalipour… - Biomedicine, 2018 - ncbi.nlm.nih.gov
Background: The incidence of kidney cancer from different areas of Iran was reported.
Nevertheless, there is no available systematic reviews in this regard. Therefore, the present …